235 related articles for article (PubMed ID: 36143233)
1. Downstream Alternate Start Site Allows N-Terminal Nonsense Variants to Escape NMD and Results in Functional Recovery by Readthrough and Modulator Combination.
Bowling A; Eastman A; Merlo C; Lin G; West N; Patel S; Cutting G; Sharma N
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143233
[TBL] [Abstract][Full Text] [Related]
2. Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations.
Mutyam V; Sharma J; Li Y; Peng N; Chen J; Tang LP; Falk Libby E; Singh AK; Conrath K; Rowe SM
Am J Respir Cell Mol Biol; 2021 May; 64(5):604-616. PubMed ID: 33616476
[TBL] [Abstract][Full Text] [Related]
3. The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators.
Chen J; Thrasher K; Fu L; Wang W; Aghamohammadzadeh S; Wen H; Tang L; Keeling KM; Falk Libby E; Bedwell DM; Rowe SM
Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L756-L770. PubMed ID: 37014818
[TBL] [Abstract][Full Text] [Related]
4. Readthrough-induced misincorporated amino acid ratios guide mutant-specific therapeutic approaches for two CFTR nonsense mutations.
Premchandar A; Ming R; Baiad A; Da Fonte DF; Xu H; Faubert D; Veit G; Lukacs GL
Front Pharmacol; 2024; 15():1389586. PubMed ID: 38725656
[TBL] [Abstract][Full Text] [Related]
5. Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis.
Sharma N; Evans TA; Pellicore MJ; Davis E; Aksit MA; McCague AF; Joynt AT; Lu Z; Han ST; Anzmann AF; Lam AN; Thaxton A; West N; Merlo C; Gottschalk LB; Raraigh KS; Sosnay PR; Cotton CU; Cutting GR
PLoS Genet; 2018 Nov; 14(11):e1007723. PubMed ID: 30444886
[TBL] [Abstract][Full Text] [Related]
6. Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations.
McHugh DR; Cotton CU; Hodges CA
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396210
[TBL] [Abstract][Full Text] [Related]
7. Integrity and Stability of PTC Bearing CFTR mRNA and Relevance to Future Modulator Therapies in Cystic Fibrosis.
Clarke LA; Luz VCC; Targowski S; Ramalho SS; Farinha CM; Amaral MD
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828417
[TBL] [Abstract][Full Text] [Related]
8. Functional Restoration of CFTR Nonsense Mutations in Intestinal Organoids.
de Poel E; Spelier S; Suen SWF; Kruisselbrink E; Graeber SY; Mall MA; Weersink EJM; van der Eerden MM; Koppelman GH; van der Ent CK; Beekman JM
J Cyst Fibros; 2022 Mar; 21(2):246-253. PubMed ID: 34666947
[TBL] [Abstract][Full Text] [Related]
9. Nonsense-mediated mRNA decay and cystic fibrosis.
Linde L; Kerem B
Methods Mol Biol; 2011; 741():137-54. PubMed ID: 21594783
[TBL] [Abstract][Full Text] [Related]
10. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.
Linde L; Boelz S; Nissim-Rafinia M; Oren YS; Wilschanski M; Yaacov Y; Virgilis D; Neu-Yilik G; Kulozik AE; Kerem E; Kerem B
J Clin Invest; 2007 Mar; 117(3):683-92. PubMed ID: 17290305
[TBL] [Abstract][Full Text] [Related]
11. Caffeine boosts Ataluren's readthrough activity.
Lentini L; Melfi R; Cancemi P; Pibiri I; Di Leonardo A
Heliyon; 2019 Jun; 5(6):e01963. PubMed ID: 31294114
[TBL] [Abstract][Full Text] [Related]
12. A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion.
Sharma J; Du M; Wong E; Mutyam V; Li Y; Chen J; Wangen J; Thrasher K; Fu L; Peng N; Tang L; Liu K; Mathew B; Bostwick RJ; Augelli-Szafran CE; Bihler H; Liang F; Mahiou J; Saltz J; Rab A; Hong J; Sorscher EJ; Mendenhall EM; Coppola CJ; Keeling KM; Green R; Mense M; Suto MJ; Rowe SM; Bedwell DM
Nat Commun; 2021 Jul; 12(1):4358. PubMed ID: 34272367
[TBL] [Abstract][Full Text] [Related]
13. CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway.
Sanderlin EJ; Keenan MM; Mense M; Revenko AS; Monia BP; Guo S; Huang L
Nat Commun; 2022 Apr; 13(1):2344. PubMed ID: 35487895
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene.
Venturini A; Borrelli A; Musante I; Scudieri P; Capurro V; Renda M; Pedemonte N; Galietta LJV
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769402
[TBL] [Abstract][Full Text] [Related]
15. Positional effects of premature termination codons on the biochemical and biophysical properties of CFTR.
Yeh JT; Hwang TC
J Physiol; 2020 Feb; 598(3):517-541. PubMed ID: 31585024
[TBL] [Abstract][Full Text] [Related]
16. The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis.
Clarke LA; Awatade NT; Felício VM; Silva IA; Calucho M; Pereira L; Azevedo P; Cavaco J; Barreto C; Bertuzzo C; Gartner S; Beekman J; Amaral MD
Hum Mutat; 2019 Mar; 40(3):326-334. PubMed ID: 30488522
[TBL] [Abstract][Full Text] [Related]
17. Decreased mRNA and protein stability of W1282X limits response to modulator therapy.
Aksit MA; Bowling AD; Evans TA; Joynt AT; Osorio D; Patel S; West N; Merlo C; Sosnay PR; Cutting GR; Sharma N
J Cyst Fibros; 2019 Sep; 18(5):606-613. PubMed ID: 30803905
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough.
Lee RE; Lewis CA; He L; Bulik-Sullivan EC; Gallant SC; Mascenik TM; Dang H; Cholon DM; Gentzsch M; Morton LC; Minges JT; Theile JW; Castle NA; Knowles MR; Kimple AJ; Randell SH
J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900863
[TBL] [Abstract][Full Text] [Related]
20. Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences.
Xue X; Mutyam V; Thakerar A; Mobley J; Bridges RJ; Rowe SM; Keeling KM; Bedwell DM
Hum Mol Genet; 2017 Aug; 26(16):3116-3129. PubMed ID: 28575328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
